Related references
Note: Only part of the references are listed.Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department
ANNALS OF EMERGENCY MEDICINE (2013)
Evidence for the efficacy of statins in animal stroke models: a meta-analysis
Lidia Garcia-Bonilla et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Statin Therapy and the Risk of Intracerebral Hemorrhage A Meta-Analysis of 31 Randomized Controlled Trials
James S. McKinney et al.
STROKE (2012)
Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia
Lidia Garcia-Bonilla et al.
BRAIN RESEARCH (2011)
Statin Use and Functional Outcome after Tissue Plasminogen Activator Treatment in Acute Ischaemic Stroke
I. Miedema et al.
CEREBROVASCULAR DISEASES (2010)
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis
Emily S. Sena et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke
Ayush Batra et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Plasma VAP-1/SSAO Activity Predicts Intracranial Hemorrhages and Adverse Neurological Outcome After Tissue Plasminogen Activator Treatment in Stroke
Mar Hernandez-Guillamon et al.
STROKE (2010)
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits
Paul A. Lapchak et al.
BRAIN RESEARCH (2009)
Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats
Li Zhang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Plasma and Brain Matrix Metalloproteinase-9 After Acute Focal Cerebral Ischemia in Rats
Kyung-Pil Park et al.
STROKE (2009)
Prior Statin Use, Intracranial Hemorrhage, and Outcome After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Niklaus Meier et al.
STROKE (2009)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial
J. Montaner et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator
Jose Alvarez-Sabin et al.
STROKE (2007)
Acute neurovascular unit protection by simvastatin in transient cerebral ischemia
Tavarekere N. Nagaraja et al.
NEUROLOGICAL RESEARCH (2006)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat
L Zhang et al.
CIRCULATION (2005)
Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke
AP Shabanzadeh et al.
BRAIN RESEARCH (2005)
Inhibition of NOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia
FJ Pérez-Asenio et al.
NEUROBIOLOGY OF DISEASE (2005)
Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase
E Kilic et al.
STROKE (2005)
Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice
JL Chen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Favorable outcome of ischemic stroke in patients pretreated with statins
J Martí-Fábregas et al.
STROKE (2004)
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction - A myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) substudy
DD Waters et al.
CIRCULATION (2002)
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats
T Sumii et al.
STROKE (2002)
Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury
W Balduini et al.
STROKE (2001)
Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study
N Jonsson et al.
STROKE (2001)
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice
S Amin-Hanjani et al.
STROKE (2001)
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
U Laufs et al.
STROKE (2000)
Share Paper
